|
 |
 |
|||||||||
 |
 |
||||||||||
| ABOUT US |  | NEWS & EVENTS | | RESOURCES | | OUR BRANDS |  |
- Home
- IFCC/AACC
- AACC 2006
- Magellan Logos
- ABOUT US
- NEWS & EVENTS
- News releases
- FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre® In Vitro Diagnostic (IVD) MIC Susceptibility Plates
- Hiroshi Uchida Named President and CEO of Magellan
- TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products
- Magellan Biosciences Sells its Life Sciences Tools Business to Dionex Company to focus on clinical-diagnostic systems and tests designed to help doctors make faster, more-informed treatment decisions
- Magellan Diagnostic Businesses to Feature Automated Systems and Diagnostic Tests at Clinical Lab Expo
- FDA Clears Caspofungin (Cancidas®) Susceptibility Testing for TREK Sensititre® YeastOne® in Vitro Diagnostics (IVD) Product Line
- TREK to Introduce New In Vitro Diagnostic and Research-Use-Only Susceptibility Products at American Society for Microbiology General Meeting, Booth 130!
- Magellan To Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute Leadcare® II Test Identifies Children With Lead Poisoning
- Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo
- ESA Names James P. Whelan Vice President, Sales & Marketing, Clinical Diagnostic Products
- Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
- Dynex Technologies to Demonstrate Automated Processing Systems for Clinical-Diagnostic Assays at Medica 2007 Hall 3, Stand D45-6
- ESA Biosciences Features Three-Minute Point-of-Care Test to Screen Children for Lead Poisoning at American Academy of Pediatrics Meeting, Booth 548
- Heiner Dreismann, PhD, Laurence R. McCarthy, PhD, and Stuart A. Auerbach Join Magellan Biosciences’ Board of Directors
- Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
- Magellan Biosciences Companies to Feature Products Designed to Improve Health Outcomes at AACC/ASCLS Clinical Lab Expo, Booth 2647
- Magellan Biosciences Sells TekCel to Hamilton Company; Focuses on Expanding Presence in Clinical-Diagnostics Market
- Magellan Biosciences Expands Presence in Hospital-Based Laboratory Market with Acquisition of TREK Diagnostic Systems
- Magellan Biosciences Closes $50 Million Financing
- ESA Biosciences to Launch CLIA-Waived LeadCare II at American Academy of Pediatrics Meeting, October 7-10, Booth 1062
- Magellan Biosciences Subsidiary Receives CLIA Waiver from FDA for LeadCare II
- Magellan Names Michael E. Woehler, PhD to the Board of Directors
- Magellan to Demonstrate Novel Clinical-Diagnostic Systems at Clinical Lab Expo 2006 Booth # 548
- TekCel and Dynex Technologies Feature Walk-away Automation at LabAutomation2006
- Dynex Technologies to Introduce Groundbreaking Clinical-Diagnostic Workstation for Near-Patient Labs at 2005 Medica
- Magellan Biosciences to Showcase its ESA and Dynex Products for Brain Research at Neuroscience 2005 in Washington, DC, November 12-16, Booth 1928
- Magellan Biosciences to Showcase its ESA and Dynex Products for Brain Research at Neuroscience 2005 in Washington, DC, November 12-16, Booth 1928
- Magellan Biosciences CEO Robert J. Rosenthal to Present at the Thomas Weisel Partners Healthcare Tailwinds Conference September 7, 2005
- Magellan Biosciences and ESA to Host Delegation from the Beijing CDC in U.S. to Study U.S. Lead-Poisoning Prevention Programs
- Dynex Partners with The Binding Site to Provide Automated and Validated Systems for Autoimmune and Infectious-Disease Assays, as well as 24/7 Service and Support
- Darren Braccia Joins Magellan Biosciences as Vice President of Business Development
- ESA Corona® CAD® Wins 2005 R&D 100 Award
- Magellan Biosciences to Showcase its ESA and Dynex Products for Clinical Diagnostics and Research at AACC in Orlando July 24-28, Booth 2828
- With TekCel Acquisition, Magellan Biosciences Adds Automated Sample-Management to Advanced-Technology Portfolio for Life Science Customers
- Magellan in the news (OLD)
- Magellan in the news
- Quick facts
- Presentations
- LeadCare® II in the news
- News releases
- RESOURCES
- Product literature
- Dynex
- ESA
- Measurement of In Vivo Biogenica Amines in Microdialysis perfusates
- Measurement of Fatty Acids and Esters at low nanogram levels
- Measurement of Simple Carbohydrates at low nanogram levels
- Use of Gradient HPLC-ECD for detection of formation of DNA Adducts from Oxidative Damage
- Molecular Proteomics™- Interface between Proteomics and Chemical Biology
- Review of the Performance Characteristics of the LeadCare® Blood Lead Testing System
- On-Site Lead Testing with LeadCare® Analyzer
- Drug Profiling- High Throughput Predictive Stability
- Measurement of Priority Phenols in Water- Analytical Methodology
- Universal HPLC Detection- Corona® CAD®- Charged Aerosol Detector for HPLC
- DiscovArray™ the Multi-functional Choice for Drug Discovery: A Powerful Tool for Pharmaceutical Scientists
- Fractionated Free Metanephrines in Plasma for Diagnostic Use by HPLC-ECD
- HPLC- Expanded Capabilities in Bioanalysis
- Identification & Measurement of Physiologically Relevant Small Molecules w/ the ESA Metabolomics™ System
- Coulometric Assisted Ionization expands the utlility and Application of Mass Spectrometers
- Electrode and Photdiode Arrays for detection and quantifing compounds by HPLC
- Electrochemistry- Mass Spectrometry with Coulochem® III-MS
- ESA Specialty Detectors for HPLC
- TREK
- Other resources
- Glossary
- Lead-poisoning resources
- LeadCare® II in the news
- Product literature
- OUR BRANDS
- PRODUCTS
- Site map
- Terms and Conditions of Use
- Privacy Policy
| Site map | Terms and Conditions of Use | Privacy Policy | ©2005-2010. Magellan Biosciences, Inc. All rights reserved. | CONTACT US | HOME |